Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial
By
- AMS
posted
Oct 20, 2020 08:34 AM
0
Recommend
.
0 comments
1 view
Permalink
Related Content
Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids
- AMS
Added Mar 04, 2020
Blog Entry
The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial
- AMS
Added Jun 08, 2020
Blog Entry
Intralesional corticosteroid injections are less painful without local anesthetic: a double-blind, randomized controlled trial
- AMS
Added Apr 07, 2021
Blog Entry
A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata
- AMS
Added Jun 09, 2020
Blog Entry
Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- AMS
Added Apr 20, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic